Switch to:
More From Other Websites
Incyte Treats First Patient in Phase II GVHD Study on Jakafi Jan 02 2017
Abbott Labs to Close St. Jude Acquisition Later this Week Jan 02 2017
HESKA CORP Files SEC form 8-K, Change in Directors or Principal Officers Dec 30 2016
Cempra (CEMP) Gets CRL from FDA for Pneumonia Candidate Dec 30 2016
Corbus Concludes Phase II study of Cystic Fibrosis Candidate Dec 30 2016
Achillion Receives $15M from J&J for HCV Study Enrolment Dec 29 2016
Shire Gets FDA Approval for Label Expansion of Adynovate Dec 28 2016
Apricus Launches Vitaros in Lebanon for Erectile Dysfunction Dec 28 2016
Neothetics (NEOT) Begins Phase II Study on Lead Candidate Dec 28 2016
Horizon's Rare Disease Drug Quinsair Launched in Canada Dec 27 2016
Ionis Receives $5 Million Milestone from J&J Unit for GI Drug Dec 23 2016
Celgene's Otezla Gains Positive Recommendation from NICE Dec 23 2016
Roche (RHHBY) Hemophilia A Drug Positive in Phase III Dec 23 2016
Bristol-Myers, Calithera Team Up for Opdivo/CB-839 Combo Dec 22 2016
Incyte/Merus Ink Collaboration for Bispecific Antibodies Dec 22 2016
Pfizer (PFE) Nimenrix Vaccine's Label Expanded in the EU Dec 21 2016
Juno Gets Breakthrough Therapy Status for Lymphoma Drug Dec 21 2016
ACADIA Phase II Alzheimer's Drug Hits Primary Endpoint Dec 21 2016
J&J Files for FDA Approval of Simponi Aria Label Expansion Dec 21 2016
Amgen Files for Approval of Osteoporosis Drug in Japan Dec 20 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK